Clinical trial

Dietary Sugar Absorptive Phenotype for Prediction of Weight Loss Outcome

NCT05408728

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

PROCEDURE · Unmapped registry intervention Endoscopic biopsy Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Dietary Sugar Absorptive Phenotype for Prediction of Weight Loss Outcome

Design: OBSERVATIONAL · Status: ENROLLING BY INVITATION · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusENROLLING_BY_INVITATION

Study typeOBSERVATIONAL

Start date2026-07-01

PhaseN/A

Conditions

Obeseunresolved

Healthyunresolved

Bariatric Surgery Candidateunresolved

Interventions

Endoscopic biopsyPROCEDURE

Sponsors & collaborators

Mayo Cliniclead sponsor

Mapped research locations

JacksonvilleFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05408728 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.